boston scientific corp (BSX:New York)

Executive Profile*

Background*

Mr. Michael F. Mahoney, Mike has been the Chief Executive Officer of Boston Scientific Corporation since November 1, 2012 and as its President since October 17, 2011. At Boston Scientific Corporation, Mr. Mahoney is responsible for Boston Scientific's Cardiac Rhythm Management (CRM) and Endoscopy (GI and Pulmonary) businesses, as well as certain corporate functions. He joined Boston Scientific in October 2011, having established a track record of more than 22 years of ... healthcare experience in building market leading global businesses in medical devices, capital equipment, and healthcare IT service businesses at best-in-class companies. Prior to joining Boston Scientific, he served as Worldwide Chairman of Medical Device and Diagnostics Group (MD&D) at Johnson & Johnson since January 3, 2011. He served as a Group Chairman, DePuy Franchise of Johnson & Johnson until January 3, 2011. In this role, he successfully drove a growth strategy via product innovation, multiple acquisitions, and International expansion, particularly in China and India. Prior to joining Johnson & Johnson, Mr. Mahoney served as the President and Chief Executive Officer of Global Healthcare Exchange (GHX). He built Global Healthcare Exchange through organic development and strategic acquisitions, successfully integrating seven acquisitions and expanding the business into Europe and Canada. He built his early career at General Electric Medical Systems, where he spent 12 years, in a variety of advancing leadership roles for domestic and global businesses in CT, MRI, X-ray, Healthcare IT, and Nuclear Medicine, culminating in the role of General Manager of the Healthcare Information Technology business. He serves as a Director of Boston Scientific Corporation. Mr. Mahoney earned a B.B.A. in Finance from the University of Iowa and a M.B.A. from Wake Forest University.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
BSX:US	$9.23 USD	-0.02

COMPETITOR COMPENSATION